Longitudinal microbial and molecular dynamics in the cystic fibrosis lung after Elexacaftor-Tezacaftor-Ivacaftor therapy.

"Declarations Ethics approval and consent to participateThis study adhered to the principles outlined in the Declaration of Helsinki. Ethical approval and written informed consent for subject participation were performed at the University of California San Diego adult CF clinic. Authorization for participation was granted by the UCSD Human Research Protections Program Institutional Review Board under protocol #160078. Consent for publicationNot applicable. Competing interestsAll authors in the presented study have no conflicts of interest to disclose. Competing interests All authors in the presented study have no conflicts of interest to disclose."

"Funding This project was funded by the National Institute of Health’s National Institute of Allergy and Infectious Diseases grant R01AI145925 awarded to Robert Quinn. Stefanie Widder was supported by the Austrian Science Fund (FWF) Elise Richter project V585-B31."